An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report

doi:10.5306/wjco.v2.i7.299

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3256)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

436

HTML

2371

Figures (1-2)

222

Tables (1-1)

227

Sum=3256

Jul 10, 2011 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Jul 10, 2011; 2(7): 299-302
Published online Jul 10, 2011. doi: 10.5306/wjco.v2.i7.299

Full Size Figure Download Figure

Figure 2 Chest radiograph and computed tomography findings 16 d after initiating steroid therapy. Chest radiograph (A) and computed tomography (B) findings were substantially improved 16 d after initiating steroid pulse therapy.

Citation: Yamane H, Kinugawa M, Umemura S, Shiote Y, Kudo K, Suwaki T, Kamei H, Takigawa N, Kiura K. An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report. World J Clin Oncol 2011; 2(7): 299-302
URL: https://www.wjgnet.com/2218-4333/full/v2/i7/299.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i7.299